Coverage of Vancomycin and Zosyn Against Gram-Negative Rods
Vancomycin does NOT cover gram-negative rods, while Zosyn (piperacillin/tazobactam) provides excellent coverage against most gram-negative rods, including Pseudomonas aeruginosa. 1, 2, 3
Vancomycin Spectrum: Gram-Positive Only
Vancomycin is active exclusively against gram-positive organisms and has no clinically relevant activity against gram-negative bacilli. 2, 1
- Vancomycin's spectrum includes staphylococci (including MRSA), streptococci, enterococci, and certain gram-positive bacilli, but it is completely inactive against gram-negative bacteria 2, 4, 5
- The outer membrane of gram-negative bacteria prevents vancomycin from reaching its site of action on the cell wall 1
- FDA labeling explicitly states: "Vancomycin is not active in vitro against gram-negative bacilli, mycobacteria, or fungi" 2
Zosyn (Piperacillin/Tazobactam) Spectrum: Broad Gram-Negative Coverage
Piperacillin/tazobactam provides robust coverage against a wide range of gram-negative rods and is specifically recommended for gram-negative infections. 6, 3
- Piperacillin/tazobactam has demonstrated excellent results for gram-negative infections and is recommended as monotherapy for empirical coverage 6
- FDA-approved coverage includes: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa (when combined with an aminoglycoside), Acinetobacter baumannii, Haemophilus influenzae, Proteus species, Serratia marcescens, Citrobacter, Morganella, and Providencia species 3
- The tazobactam component inhibits beta-lactamases, extending coverage to many resistant gram-negative organisms 3
Clinical Implications for Empirical Therapy
When gram-negative coverage is needed, use piperacillin/tazobactam; vancomycin should only be added when specific gram-positive indications exist. 6, 7
- For suspected gram-negative infections (including Klebsiella species), appropriate empirical therapy must include antibiotics with gram-negative coverage such as piperacillin/tazobactam, cephalosporins with antipseudomonal activity, or carbapenems 6, 1
- Vancomycin should be added to a gram-negative regimen only when there are specific indications: hemodynamic instability, severe sepsis, suspected catheter-related infection, positive blood cultures for gram-positive bacteria, or known MRSA colonization 7
- Empirical vancomycin use should be discontinued after 72-96 hours if cultures remain negative for gram-positive organisms 6
Common Pitfall to Avoid
Do not rely on vancomycin for any gram-negative coverage—it provides none. 1, 2
- In mixed infections requiring both gram-positive and gram-negative coverage, vancomycin must be combined with appropriate gram-negative agents like piperacillin/tazobactam 7
- The combination of vancomycin plus piperacillin/tazobactam provides comprehensive coverage for both gram-positive (including MRSA) and gram-negative organisms (including Pseudomonas) 7, 3